The expected issuance of this patent further expands Nutriband’s intellectual property protection in the United States for its portfolio of abuse deterrent transdermal products based on its ...
This technology can be incorporated into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. Nutriband’s lead product under ...
(MENAFN- GlobeNewsWire - Nasdaq) The AVERSATM transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 ...
This technology can be incorporated into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. Nutriband’s lead product under ...
The AVERSAâ„¢ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe ...
The AVERSAâ„¢ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results